Literature DB >> 24866815

Intraoperative electrocorticography-guided microsurgical management for patients with onset of supratentorial neoplasms manifesting as epilepsy: a review of 65 cases.

Bo Qiu1, Shaowu Ou1, Teng Song1, Jinqu Hu1, Lingtong You1, Yong Wang1, Yunjie Wang1.   

Abstract

AIM: We reviewed the surgical procedures guided by intraoperative electrocorticography and outcome of 65 patients with onset of supratentorial neoplasms manifesting as epilepsy.
METHOD: Clinical data were obtained for 65 patients with supratentorial neoplasms who received surgery, with the aid of intraoperative electrocorticography to screen epileptogenic foci before and after removal of neoplasms, and depth electrodes when needed. According to electrocorticography findings, appropriate surgical procedures were performed to treat the epileptogenic foci. In the control group, 72 patients received simple lesionectomy. Postoperative seizure outcomes were documented and analysed retrospectively.
RESULTS: In the case group, 33 patients received lesionectomy only, while the other 32 patients underwent intraoperative electrocorticography-guided tailored epilepsy surgery. In total, 57 patients (87.7%) in the case group and 38 patients (52.8%) in the control group were seizure-free (Engel Class I). Comparing outcomes of patients with temporal lesions between the two groups, 80.0% patients (12/15) in the case group and 20.0% (3/15) in the control group were seizure-free. Furthermore, comparing the seizure outcomes of patients who finally underwent tailored epilepsy surgery and simple lesionectomy (33 after electrocorticography and 72 without electrocorticography), intraoperative electrocorticography-guided tailored epilepsy surgery demonstrated superiority over lesionectomy (Engel Class I; 87.5% vs. 63.8%, respectively).
CONCLUSIONS: Electrocorticography plays an important role in the localisation of epileptogenic foci and evaluation of the effects of microsurgical procedures intraoperatively. Isolated lesionectomy is not usually sufficient for better postoperative seizure outcome. In addition, for patients with temporal tumours, especially in the non-dominant hemisphere, a more aggressive strategy, such as an anterior temporal lobectomy, is recommended.

Entities:  

Keywords:  electrocorticography; epilepsy; epileptogenic focus; microsurgery; neoplasm

Mesh:

Year:  2014        PMID: 24866815     DOI: 10.1684/epd.2014.0662

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  6 in total

Review 1.  Approach to cortical dysplasia associated with glial and glioneuronal tumors (FCD type IIIb).

Authors:  Marcelo Volpon Santos; Ricardo Santos de Oliveira; Hélio Rubens Machado
Journal:  Childs Nerv Syst       Date:  2014-10-09       Impact factor: 1.475

2.  Clinical Relevance of Interictal Spikes in Tumor-Related Epilepsy: An Electrocorticographic Study.

Authors:  Changik Lee; Woorim Jeong; Chun Kee Chung
Journal:  J Epilepsy Res       Date:  2019-12-31

3.  Factors associated with seizure and cognitive outcomes after epilepsy surgery for low-grade epilepsy-associated neuroepithelial tumors in children.

Authors:  Ara Ko; Joon Soo Lee
Journal:  Clin Exp Pediatr       Date:  2019-11-13

4.  Scale-Free Analysis of Intraoperative ECoG During Awake Craniotomy for Glioma.

Authors:  Diana Cristina Ghinda; Ben Lambert; Junfeng Lu; Ning Jiang; Eve Tsai; Adam Sachs; Jin-Song Wu; Georg Northoff
Journal:  Front Oncol       Date:  2021-02-23       Impact factor: 6.244

5.  Epilepsy surgery for low-grade epilepsy-associated neuroepithelial tumor of temporal lobe: a single-institution experience of 61 patients.

Authors:  Zhe Zheng; Hongjie Jiang; Hemmings Wu; Yao Ding; Shuang Wang; Wenjie Ming; Junming Zhu
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

6.  Early Epilepsy Surgery in Benign Cerebral Tumors: Avoid Your 'Low-Grade' Becoming a 'Long-Term' Epilepsy-Associated Tumor.

Authors:  Catrin Mann; Nadine Conradi; Elisabeth Neuhaus; Jürgen Konczalla; Thomas M Freiman; Andrea Spyrantis; Katharina Weber; Patrick Harter; Felix Rosenow; Adam Strzelczyk; Susanne Schubert-Bast
Journal:  J Clin Med       Date:  2022-10-05       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.